...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Japanese publication response from IR
Reply New Message
Back To Forum List View
Japanese publication response from IR
5
Nextblockbuster
Nov 01, 2016 08:32AM
Icon president Re: Japanese publication response from IR
6
BearDownAZ
Nov 01, 2016 02:09PM
Icon president Re: Japanese publication response from IR
1
SanFrancisco99
Nov 01, 2016 03:08PM
Icon president Re: Japanese publication response from IR
2
BearDownAZ
Nov 01, 2016 04:09PM
Icon president Re: Japanese publication response from IR
3
SanFrancisco99
Nov 01, 2016 04:38PM

Another potentially interesting insignt into this potential Zenith - Japanese relationship. A couple of tweets from October 12th that I just noticed today. Nothing definitive here so.....DYODD. I'm just sharing what I saw on the twitter-verse.

Life_Science_CanJP (‏@kats1702) Oct 12

#Canadian Ambassador opens CDN life science seminar featuring #Zenith Epigenetics & #Telesta at @BioJapan_ICS

https://twitter.com/kats1702/status/786165527865470976

Ian Burney ‏(@IanBurneyJapan) Oct 12

Advancing Can-Japan partnerships in #cancer #immunotherapy @BioJapan_ICS. Full house for #telestatherapeutics #zenithepigenetics seminar.

https://twitter.com/IanBurneyJapan/status/786361071653130241

3 Recommendations
Icon president Re: Japanese publication response from IR
4
BearDownAZ
Nov 12, 2016 04:10PM
Icon president Re: Japanese publication response from IR
1
SanFrancisco99
Nov 12, 2016 11:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply